Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05859074Phase 1Recruiting
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
Adnexal CarcinomaAdvanced CancerAngiosarcoma+16 more
PrincipalinvestigatorStart date: 2023-05-04
NCT04722523Phase 1Recruiting
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead Cancer+3 more
PrincipalinvestigatorStart date: 2021-01-20
NCT03524326Phase 1Completed
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Cutaneous Squamous Cell CarcinomaHead and Neck CancerHead and Neck Carcinoma+1 more
PrincipalinvestigatorStart date: 2018-04-30

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckSquamous Cell Carcinoma of Head and NeckMetastatic Cancer+1 more

Worked with same sponsors:

Memorial Sloan Kettering Cancer CenterRegeneron Pharmaceuticals
Similarity Score5%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

MelanomaMetastatic CancerSolid Tumor
Similarity Score4%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaMetastatic Cancer
Similarity Score3%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Merkel Cell
Similarity Score3%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Cancer of Head and NeckMetastatic Cancer
Similarity Score3%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorAdvanced Cancer
Similarity Score3%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of Head and NeckSolid Tumor
Similarity Score3%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Merkel Cell
Similarity Score3%

Mike Royal, MD

Sorrento Therapeutics, Inc.

Related
19 trials

Shared therapeutic areas:

Solid TumorRefractory Cancer
Similarity Score3%

lin shen

Peking University Cancer Hospital & Institute

Related
31 trials

Shared therapeutic areas:

Solid TumorMelanoma
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05859074Phase 1PrincipalInvestigator

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Adnexal CarcinomaAdvanced CancerAngiosarcoma+16 more
Recruiting
NCT04722523Phase 1PrincipalInvestigator

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead Cancer+3 more
Recruiting
NCT03524326Phase 1PrincipalInvestigator

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell CarcinomaHead and Neck CancerHead and Neck Carcinoma+1 more
Completed

All 3 trials loaded